ArticleBlood2010

The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.

Michael Hudecek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.